FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 10378119 · Received August 7, 2020

Report

Report Number
3004464228-2020-12553
Event Type
Malfunction
Date Received
August 7, 2020
Date of Event
August 5, 2020
Report Date
August 6, 2020
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K162296
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE POD WAS RECEIVED WITH THE CANNULA DEPLOYED. THE DOWNLOAD DATA SHOWED THAT THE DEVICE RAN 55 PULSES AND WAS DEACTIVATED AFTER COMPLETION OF THE SECOND PRIMING SEQUENCE. NO ISSUES WERE FOUND THAT WOULD RESULT IN A NEEDLE MECHANISM FAILURE. IT COULD NOT BE DETERMINED WHEN THE NEEDLE DEPLOYED. PER NEW INFORMATION, THE FOLLOWING WERE UPDATED. D1 - BRAND NAME CHANGED FROM OMNIPOD INSULIN PUMP TO OMNIPOD INSULIN MANAGEMENT SYSTEM. D4 - MODEL NO CHANGED FROM 14810 TO 19191. D4 - LOT NO CHANGED FROM BLANK TO L45759. D4 - CATALOG NO CHANGED FROM ZXY425 TO ZXP425. D4 - EXPIRATION DATE CHANGED FROM BLANK TO 11/9/2021. D4 - UNIQUE IDENTIFIER (UDI) # CHANGED FROM (B)(4) TO (B)(4). G5 - PMA/510(K) # CHANGED FROM K192659 TO K162296. H4 - DEVICE MFG DATE CHANGED FROM BLANK TO 5/9/2020.

Additional Manufacturer Narrative · 1

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO CONFIRM THE REPORTED NEEDLE MECHANISM FAILURE OR TO DETERMINE ITS ROOT CAUSE. NO LOT RELEASE RECORDS WERE REVIEWED, AS THE PRODUCT LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THE NEEDLE DEPLOYED EARLY, INDICATING A NEEDLE MECHANISM FAILURE. THE PATIENT'S BLOOD GLUCOSE LEVELS WERE UNAFFECTED, AND THE POD WAS NOT WORN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
843156 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L45759

Patients

Seq Age Sex Outcome Treatment
1 120 YR